Commit To Purchase GenMark Diagnostics At $2.50, Earn 9.4% Annualized Using Options
February 14, 2018 at 12:04 PM EST
Investors considering a purchase of GenMark Diagnostics, Inc. (GNMK) shares, but cautious about paying the going market price of $4.48/share, might benefit from considering selling puts among the alternative strategies at their disposal..
